Therefore, when considering the prognostic impact of FAM83H/ZNF16 expression in gallbladder carcinomas, further study is needed to find specific therapeutics targeting the FAM83H/ZNF16 pathway. This evidence concerns the gene SACK1H and gallbladder carcinoma.